LAZYDAYS HOLDINGS INC (GORV)

US52110H1005 - Common Stock

0.8307  +0.04 (+5.15%)

After market: 0.87 +0.04 (+4.73%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GORV. GORV was compared to 122 industry peers in the Specialty Retail industry. GORV may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, GORV is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year GORV has reported negative net income.
GORV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: GORV reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: GORV reported negative operating cash flow in multiple years.

1.2 Ratios

GORV has a worse Return On Assets (-27.07%) than 87.60% of its industry peers.
GORV's Return On Equity of -152.15% is on the low side compared to the rest of the industry. GORV is outperformed by 79.34% of its industry peers.
Industry RankSector Rank
ROA -27.07%
ROE -152.15%
ROIC N/A
ROA(3y)2.07%
ROA(5y)1.55%
ROE(3y)-1.1%
ROE(5y)0.31%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GORV's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 18.81%, GORV is doing worse than 82.64% of the companies in the same industry.
GORV's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for GORV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.81%
OM growth 3Y-43.99%
OM growth 5Y-17.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5Y-0.49%

0

2. Health

2.1 Basic Checks

GORV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GORV has more shares outstanding
GORV has more shares outstanding than it did 5 years ago.
GORV has a worse debt/assets ratio than last year.

2.2 Solvency

GORV has an Altman-Z score of 1.00. This is a bad value and indicates that GORV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of GORV (1.00) is worse than 73.55% of its industry peers.
A Debt/Equity ratio of 3.09 is on the high side and indicates that GORV has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 3.09, GORV is doing worse than 75.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.09
Debt/FCF N/A
Altman-Z 1
ROIC/WACCN/A
WACC2.34%

2.3 Liquidity

GORV has a Current Ratio of 0.91. This is a bad value and indicates that GORV is not financially healthy enough and could expect problems in meeting its short term obligations.
GORV has a Current ratio of 0.91. This is amonst the worse of the industry: GORV underperforms 81.82% of its industry peers.
A Quick Ratio of 0.12 indicates that GORV may have some problems paying its short term obligations.
The Quick ratio of GORV (0.12) is worse than 92.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.12

4

3. Growth

3.1 Past

The earnings per share for GORV have decreased strongly by -602.60% in the last year.
Looking at the last year, GORV shows a very negative growth in Revenue. The Revenue has decreased by -18.39% in the last year.
GORV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.23% yearly.
EPS 1Y (TTM)-602.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.58%
Revenue 1Y (TTM)-18.39%
Revenue growth 3Y9.84%
Revenue growth 5Y12.23%
Sales Q2Q%-23.95%

3.2 Future

The Earnings Per Share is expected to grow by 29.84% on average over the next years. This is a very strong growth
GORV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.53% yearly.
EPS Next Y-288.17%
EPS Next 2Y-21.25%
EPS Next 3Y29.84%
EPS Next 5YN/A
Revenue Next Year-16.32%
Revenue Next 2Y-5.76%
Revenue Next 3Y2.3%
Revenue Next 5Y11.53%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

GORV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GORV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

GORV's earnings are expected to grow with 29.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.25%
EPS Next 3Y29.84%

0

5. Dividend

5.1 Amount

GORV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LAZYDAYS HOLDINGS INC

NASDAQ:GORV (12/20/2024, 8:15:19 PM)

After market: 0.87 +0.04 (+4.73%)

0.8307

+0.04 (+5.15%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-18 2024-11-18/amc
Earnings (Next)N/A N/A
Inst Owners75.59%
Inst Owner ChangeN/A
Ins Owners1.82%
Ins Owner Change41.95%
Market Cap49.79M
Analysts82.86
Price Target10.2 (1127.88%)
Short Float %5.87%
Short Ratio2.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)-1.56%
DP-0.6%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-256.01%
Min EPS beat(2)-472.13%
Max EPS beat(2)-39.9%
EPS beat(4)0
Avg EPS beat(4)-209.08%
Min EPS beat(4)-472.13%
Max EPS beat(4)-39.9%
EPS beat(8)1
Avg EPS beat(8)-236.84%
EPS beat(12)1
Avg EPS beat(12)-165.5%
EPS beat(16)3
Avg EPS beat(16)-124.77%
Revenue beat(2)0
Avg Revenue beat(2)-15.65%
Min Revenue beat(2)-22.97%
Max Revenue beat(2)-8.33%
Revenue beat(4)0
Avg Revenue beat(4)-12.32%
Min Revenue beat(4)-22.97%
Max Revenue beat(4)-3.1%
Revenue beat(8)0
Avg Revenue beat(8)-10.4%
Revenue beat(12)2
Avg Revenue beat(12)-6.6%
Revenue beat(16)4
Avg Revenue beat(16)-2.8%
PT rev (1m)76.47%
PT rev (3m)76.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF 2.3
P/B 0.38
P/tB 0.88
EV/EBITDA N/A
EPS(TTM)-5.41
EYN/A
EPS(NY)-2.38
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)0.36
OCFY43.56%
SpS15.36
BVpS2.18
TBVpS0.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.07%
ROE -152.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.81%
FCFM N/A
ROA(3y)2.07%
ROA(5y)1.55%
ROE(3y)-1.1%
ROE(5y)0.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.51%
ROCE(5y)15.21%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.99%
OM growth 5Y-17.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5Y-0.49%
F-Score3
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 3.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 195.31%
Cap/Sales 4.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.12
Altman-Z 1
F-Score3
WACC2.34%
ROIC/WACCN/A
Cap/Depr(3y)299.96%
Cap/Depr(5y)244.19%
Cap/Sales(3y)4.51%
Cap/Sales(5y)3.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-602.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-164.58%
EPS Next Y-288.17%
EPS Next 2Y-21.25%
EPS Next 3Y29.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.39%
Revenue growth 3Y9.84%
Revenue growth 5Y12.23%
Sales Q2Q%-23.95%
Revenue Next Year-16.32%
Revenue Next 2Y-5.76%
Revenue Next 3Y2.3%
Revenue Next 5Y11.53%
EBIT growth 1Y-276.19%
EBIT growth 3Y-38.48%
EBIT growth 5Y-7.57%
EBIT Next Year-388.36%
EBIT Next 3Y41.5%
EBIT Next 5YN/A
FCF growth 1Y84.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.86%
OCF growth 3YN/A
OCF growth 5YN/A